Rajnish Bharti- Director, Promega Biotech India Pvt. Ltd
Dr. Rajnish Bharti, a keen planner & strategist, is the Director of ‘Promega BioTech India’, which is a global leader in imparting innovative solutions and technical support to life scientists in academic, industrial and government set-ups. ‘Promega Biotech India Pvt. Ltd.’, established in 2014, is a subsidiary of ‘Promega Corporation’ operating remarkably for last 41 years.
‘Promega BioTech India’ provides customers with industry-leading services, support and rapid access to products and technologies. Owing to the 5 successful years of ‘Promega’, the company has built an outstanding portfolio of more than 4,000 products, spanning the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity.
India is emerging in biotech markets around the world with the Bio supplier Industry growing at an explicit rate of 12%. Owing to Dr. Rajnish Bharti’s expertise in marketing and business development operations, ‘Promega products’ have been remarkably capturing the Indian market since ages. “We had been operating through channel partners prior to our direct operation”, he shares.
“Though the Indian biotech industry has been progressing since few decades but the funding matrix changed by the government has triggered the slowdown of biotechnology”, reflects the business tycoon.
Adding further, he expresses that they are now more focused on the product development and translational research, admitting the fact that their biggest challenge was to establish the direct operation of ‘Promega’ from absolutely no resources in hand, in an extremely price sensitive & competitive market.
“We continue to explore the new market and try to penetrate into those unexplored areas through our sales team and influential marketing activities like road shows, seminars and digital marketing”, he asserts.
The Business Magnate, Dr. Rajnish Bharti shares, “Our products and our organization culture make us unique”.
‘Promega’ embraces the principles of emotional and social intelligence (ESI) for fostering a supportive and dynamic work environment by improving employee relationships, managing stress and strengthening the emotional infrastructure to reinforce a strong future for ‘Promega’.
The pioneer in BioTech industry- ‘Promega BioTech India Pvt Ltd.’, has added a feather in its cap with its substantially innovative products.
“Our microsatellite instability (MSI) technology helps in investigating the best treatment path for cancer, NanoBRET™ TE Intracellular Kinase Assay, for drug discovery & development, and STR chemistry for leading forensic labs in India”, shares the BioTech Magnate.